Evidence Base
How Medicare’s Evidence Requirements Create Barriers to Equitable Healthcare Access
June 4, 2026
Featured Experts: Alison Sexton Ward, PhD, Olivia Williams, Barry Liden, JD, Alice Chen, PhD, Desi Peneva, MS, Darius Lakdawalla, PhD
Research
All Research Featured Research
News
New Financing Models May Expand Access to Life-Changing Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
White Paper
High-Stakes Medicine: Rethinking Policies for the Cost and Value of Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
Comment Letter
Comments on Proposed GLOBE and GUARD Models
February 27, 2026
Featured Experts: Alice Chen, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
White Paper
Hidden Profits? How Accounting Conventions and Vertical Consolidation Can Obscure PBM Profitability
January 22, 2026
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments on National Coverage Analysis: Transcatheter Aortic Valve Replacement and Broader CED Policy Considerations
January 14, 2026
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Testimony
Testimony on Accelerating Medical Breakthroughs for American Patients and Their Families
December 9, 2025
Featured Experts: Darius Lakdawalla, PhD
Comment Letter
Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”
October 21, 2025
Featured Experts: Alice Chen, PhD, Jason Doctor, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Karen Mulligan, PhD, Desi Peneva, MS, Charles E. Phelps, PhD
News
USC Health Economist Darius Lakdawalla Elected to National Academy of Medicine
October 20, 2025
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Measuring the Budget Impact of Nondiscriminatory Cost-Effectiveness
September 5, 2025
Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Maria-Alice Manetas, Darius Lakdawalla, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation
June 27, 2025
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
News
Why Do Americans Pay More for Prescription Drugs?
June 12, 2025
Featured Experts: Darius Lakdawalla, PhD
White Paper
How Does Corporate Tax Policy Influence Innovation?
June 4, 2025
Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Darius Lakdawalla, PhD
Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems
April 14, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
Care Continuity, Nephrologists’ Dialysis Facility Preferences, and Outcomes
April 11, 2025
Featured Experts: Eugene Lin, MD, MS, Khristina Ipapo Lung, MPH, Darius Lakdawalla, PhD, Desi Peneva, MS, Karen Van Nuys, PhD
White Paper
Lifetime Social Returns From Expanding Access to Anti-Obesity Medications
March 27, 2025
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Darius Lakdawalla, PhD, Dana Goldman, PhD
